{{Rsnum
|rsid=1655285
|Gene=TSNAX
|Chromosome=1
|position=231563728
|Orientation=minus
|GMAF=0.07254
|Gene_s=MAP1LC3C,TSNAX
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 80.0 | 18.5 | 1.5
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 92.1 | 6.3 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|17673452}} 13 single-nucleotide polymorphisms (SNPs) in 723 members of 179 Finnish [[Bipolar disorder]]  families.
*[[rs751229]](T) and [[rs3738401]](A) was over-transmitted to males with psychotic disorder. 
*under-transmitted [[rs821616]](T) and [[rs1411771]](T)
*The risk haplotype for psychotic disorder also associated to perseverations (P = 0.035; for [[rs751229]] alone P = 0.0012), and a protective haplotype G-T-G with [[rs1655285]] in addition to auditory attention (P = 0.0059).

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}